Smart Nanovesicles for Drug Targeting and Delivery

ISBN 10: 3038978949 / ISBN 13: 9783038978947

Published by MDPI AG, 2019

About this Item

Smart Nanovesicles for Drug Targeting and Delivery | Taschenbuch | Kartoniert / Broschiert | Englisch | 2019 | MDPI AG | EAN 9783038978947 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.

Seller Inventory # 126047459

Bibliographic Details

• Title: Smart Nanovesicles for Drug Targeting and Delivery
• Publisher: MDPI AG
• Publication Date: 2019
• Language: English
• ISBN 10: 3038978949
• ISBN 13: 9783038978947
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 244W x 170H x 13D millimeters 244 millimeters width by 170 millimeters height by 13 millimeters depth
• Weight: 516 grams
• Seller catalogs:
  • Bücher

About this title

Synopsis

We can use the short text on the SI page for the description, or you make slight modifications on it.
The description/summary is only for promotion (flyer, distribution channels), and will not be included in the book

You can use the short text on the SI page for the description

Nanovesicles are highly-promising systems for the delivery and/or targeting of drugs, biomolecules and contrast agents. Despite the fact that initial studies in this area were performed on phospholipid vesicles, there is an ever-increasing interest in the use of other molecules to obtain smart vesicular carriers focusing on strategies for targeted delivery. These systems can be obtained using newly synthesized smart molecules, or by intelligent design of opportune carriers to achieve specific delivery to the site of action.

The drug/contrast agent-containing vesicles need to be directed to precise locations within the body to obtain desired magnitude and duration of the therapeutic or diagnostic effect. This spatial control in the delivery might open new avenues to modulate drug activity while avoiding side-effects and to optimize contrast agent properties while avoiding a broad distribution in the organism. However, delivering and targeting active substances into specific tissues and cells is still a challenge in designing novel therapeutic approaches against untreatable disorders, such as tumors and degenerative diseases.